Cargando…

Inhibition of tumour necrosis factor and IL-17 production by leflunomide involves the JAK/STAT pathway

OBJECTIVE: To study the effects of different disease-modifying antirheumatic drugs (DMARD) on different events mediated by IL-15-activated lymphocytes. METHODS: Peripheral blood lymphocytes (PBL) were isolated from healthy donors and activated with IL-15 after exposure to different DMARD: leflunomid...

Descripción completa

Detalles Bibliográficos
Autores principales:	González-Alvaro, I, Ortiz, A M, Domínguez-Jiménez, C, Aragón-Bodi, A, Sánchez, B Díaz, Sánchez-Madrid, F
Formato:	Texto
Lenguaje:	English
Publicado:	BMJ Group 2008
Materias:	Basic and Translational Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2946060/ https://www.ncbi.nlm.nih.gov/pubmed/18957484 http://dx.doi.org/10.1136/ard.2008.096743

Ejemplares similares

The JAK inhibitor tofacitinib suppresses synovial JAK1-STAT signalling in rheumatoid arthritis
por: Boyle, D L, et al.
Publicado: (2015)

EGFR blockade in GBM brain tumor stem cells synergizes with JAK2/STAT3 pathway inhibition to abrogate compensatory mechanisms in vitro and in vivo
por: Jensen, Katharine V, et al.
Publicado: (2020)

Canakinumab reverses overexpression of inflammatory response genes in tumour necrosis factor receptor-associated periodic syndrome
por: Torene, Rebecca, et al.
Publicado: (2017)

Exacerbated inflammatory arthritis in response to hyperactive gp130 signalling is independent of IL-17A
por: Jones, G W, et al.
Publicado: (2013)

Transient Inhibition of the JAK/STAT Pathway Prevents B-ALL Development in Genetically Predisposed Mice
por: Casado-García, Ana, et al.
Publicado: (2022)

IL-6-driven STAT signalling in circulating CD4+ lymphocytes is a marker for early anticitrullinated peptide antibody-negative rheumatoid arthritis
por: Anderson, Amy E, et al.
Publicado: (2016)

Growth dynamics of brain metastases differentiate radiation necrosis from recurrence
por: Ocaña-Tienda, Beatriz, et al.
Publicado: (2022)

The STAT4 SLE risk allele rs7574865[T] is associated with increased IL-12-induced IFN-γ production in T cells from patients with SLE
por: Hagberg, Niklas, et al.
Publicado: (2018)

Mode of action of abatacept in rheumatoid arthritis patients having failed tumour necrosis factor blockade: a histological, gene expression and dynamic magnetic resonance imaging pilot study
por: Buch, M H, et al.
Publicado: (2009)

Multi-OMICS analyses unveil STAT1 as a potential modifier gene in mevalonate kinase deficiency
por: Carapito, Raphael, et al.
Publicado: (2018)

Epileptic Neurons Know JAK/STAT3
por: Kumari, Shikha, et al.
Publicado: (2023)

Enzastaurin has anti-tumour effects in lung cancers with overexpressed JAK pathway molecules
por: Shimokawa, T, et al.
Publicado: (2012)

Runx1 promotes the development of glioma cells by regulating JAK-STAT signalling pathway
por: Zhang, Yong, et al.
Publicado: (2019)

Constitutive activation of the EGFR–STAT1 axis increases proliferation of meningioma tumor cells
por: Ferluga, Sara, et al.
Publicado: (2020)

Ex vivo ultrasonic samples of human brain tumors in the molecular era
por: Kirby, Alastair J, et al.
Publicado: (2020)

Multicellular “hotspots” harbor high-grade potential in lower-grade gliomas
por: Kirby, Alastair J, et al.
Publicado: (2021)

Tofacitinib regulates synovial inflammation in psoriatic arthritis, inhibiting STAT activation and induction of negative feedback inhibitors
por: Gao, W, et al.
Publicado: (2016)

Withacnistin inhibits recruitment of STAT3 and STAT5 to growth factor and cytokine receptors and induces regression of breast tumours
por: Zhang, X, et al.
Publicado: (2014)

On optimal temozolomide scheduling for slowly growing glioblastomas
por: Segura-Collar, Berta, et al.
Publicado: (2022)

Interleukin-15 and interferon-γ participate in the cross-talk between natural killer and monocytic cells required for tumour necrosis factor production
por: González-Álvaro, Isidoro, et al.
Publicado: (2006)

Soluble tumour necrosis factor receptor type II and survival in colorectal cancer
por: Babic, Ana, et al.
Publicado: (2016)

Selective blood-brain barrier permeabilization of brain metastases by a type 1 receptor-selective tumor necrosis factor mutein
por: Munoz Pinto, Mario F, et al.
Publicado: (2021)

STAT3 is a biologically relevant therapeutic target in H3K27M-mutant diffuse midline glioma
por: Zhang, Liang, et al.
Publicado: (2022)

An ankylosing spondylitis-associated genetic variant in the IL23R-IL12RB2 intergenic region modulates enhancer activity and is associated with increased Th1-cell differentiation
por: Roberts, Amity R, et al.
Publicado: (2016)

The histamine H(4) receptor mediates inflammation and Th17 responses in preclinical models of arthritis
por: Cowden, Jeffery M, et al.
Publicado: (2014)

Chromosome 17 alterations identify good-risk and poor-risk tumors independently of clinical factors in medulloblastoma
por: McCabe, Martin G., et al.
Publicado: (2011)

IL-17A induces osteoblast differentiation by activating JAK2/STAT3 in ankylosing spondylitis
por: Jo, Sungsin, et al.
Publicado: (2018)

IL-17 induces AKT-dependent IL-6/JAK2/STAT3 activation and tumor progression in hepatocellular carcinoma
por: Gu, Fang-Ming, et al.
Publicado: (2011)

A CD4 T cell gene signature for early rheumatoid arthritis implicates interleukin 6-mediated STAT3 signalling, particularly in anti-citrullinated peptide antibody-negative disease
por: Pratt, Arthur G, et al.
Publicado: (2012)

Silencing or inhibition of endoplasmic reticulum aminopeptidase 1 (ERAP1) suppresses free heavy chain expression and Th17 responses in ankylosing spondylitis
por: Chen, Liye, et al.
Publicado: (2016)

Histone deacetylase inhibitors suppress rheumatoid arthritis fibroblast-like synoviocyte and macrophage IL-6 production by accelerating mRNA decay
por: Grabiec, Aleksander M, et al.
Publicado: (2011)

Tandem chimeric antigen receptor (CAR) T cells targeting EGFRvIII and IL-13Rα2 are effective against heterogeneous glioblastoma
por: Schmidts, Andrea, et al.
Publicado: (2022)

Methotrexate limits inflammation through an A20-dependent cross-tolerance mechanism
por: Municio, Cristina, et al.
Publicado: (2018)

Cucurbitacin IIa: a novel class of anti-cancer drug inducing non-reversible actin aggregation and inhibiting survivin independent of JAK2/STAT3 phosphorylation
por: Boykin, C, et al.
Publicado: (2011)

Elevated retinol binding protein 4 levels are associated with atherosclerosis in diabetic rats via JAK2/STAT3 signaling pathway
por: Zhou, Wan, et al.
Publicado: (2021)

Phase I trial of convection-enhanced delivery of IL13RA2 and EPHA2 receptor targeted cytotoxins in dogs with spontaneous intracranial gliomas
por: Rossmeisl, John H, et al.
Publicado: (2020)

Single-cell transcriptomic analyses provide insights into the cellular origins and drivers of brain metastasis from lung adenocarcinoma
por: Wang, Zihao, et al.
Publicado: (2023)

GBMdeconvoluteR accurately infers proportions of neoplastic and immune cell populations from bulk glioblastoma transcriptomics data
por: Ajaib, Shoaib, et al.
Publicado: (2023)

Neutrophils Promote Larynx Squamous Cell Carcinoma Progression via Activating the IL-17/JAK/STAT3 Pathway
por: Liu, Tianyi, et al.
Publicado: (2021)

Heparanase Contributes to Psoriatic Lesions Through Crosstalk with IL-17 Pathway
por: Zhu, Chengyao, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_llelrrstja4vjk9siqatahj6jf